Evotec Acquires Kinaxo Biotech for up to $22M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Evotec today announced it has signed a definitive agreement to purchase Kinaxo Biotechnologies for up to €16 million ($22 million) in a cash and stock deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.